Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary EDAP Announces Presentation at the Jefferies Virtual London Healthcare Conference
LYON , France, November 10, 2020 --  EDAP TMS SA  (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that management will be presenting at the Jefferies Virtual London Healthcare Conference , which is being held November 17-19, 2020.  Presentation Details
View HTML
Toggle Summary EDAP Announces Presentation at the HC Wainwright Virtual 22nd Annual Global Investment Conference
LYON, France , September 9, 2020 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that management will be presenting at the HC Wainwright Virtual 22nd Annual Global Investment Conference , which is being held September 14-15, 2020 .  Presentation
View HTML
Toggle Summary EDAP Announces Preliminary Unaudited Full Year 2016 Revenue
EDAP Announces Preliminary Unaudited Full Year 2016 Revenue Full year 2016 revenue increased to approximately €35.6 million  2016 HIFU revenues recorded over 63% growth Strong cash position of €22 million Company to announce fourth quarter and full year 2016 results April 3rd with accompanying
View HTML
Toggle Summary EDAP Announces Preliminary Fourth Quarter Record Focal One® System Sales and Placements
Company reports preliminary placement results of twelve Focal One Systems, inclusive of ten capital sales LYON, France, January 8, 2024 - EDAP TMS SA (Nasdaq: EDAP), (“EDAP”), the global leader in robotic energy-based therapies, announced today preliminary Focal One placement results for the fourth
View HTML
Toggle Summary EDAP Announces Positive Results from Phase 2 Study Evaluating Therapeutic High-Intensity Focused Ultrasound (HIFU) for the Treatment of Rectal Endometriosis
Focal One ® HIFU treatment resulted in significant improvements in endometriosis symptoms  and quality of life (QoL) Positive safety profile with 9 6 . 7 % of patients with no or non- significant adverse events Data was presented at the Paris Santé Femmes Major Gynecology French Congress on Friday,
View HTML
Toggle Summary EDAP Announces Positive Opinion for Reimbursement from the French National Authority for Health (HAS) for HIFU treatment of Prostate Cancer
Represents Key Milestone Toward Universal Coverage for Focal One HIFU in France LYON, France, December 12, 2023 - EDAP TMS SA (Nasdaq: EDAP), (“EDAP”), the global leader in robotic energy-based therapies, today announced that the French National Authority for Health (“HAS”) released a favorable
View HTML
Toggle Summary EDAP Announces Positive 24 Month Interim Results of French Urology Association (AFU) Sponsored Clinical Study comparing HIFU to Radical Prostate Surgery
Results on 3,329 patients demonstrate significant difference in efficacy in favor of HIFU versus Radical Prostatectomy (RP) HIFU treatment also resulted in meaningful benefits in both urinary and erectile function versus RP showing superior quality of life preservation capability LYON, France ,
View HTML
Toggle Summary EDAP Announces Plans to Pursue Direct De Novo 510(k) Petition in Lieu of PMA for Its Ablatherm HIFU
FDA Meeting Held to Confirm Planned Approach
View HTML
Toggle Summary EDAP Announces Opening of two New Ablatherm-HIFU Excellence Urology Centers in the U.S.
    University of Chicago Medicine - Dr. A. Shalhav, Chair of Urology Surgery and Director of Robotic Surgery  Vituro Health LLC - Dr. S. Scionti , Medical Director and Director of The Scionti Prostate Center in Sarasota, FL LYON, France , September 19, 2017 -- EDAP TMS SA (Nasdaq:EDAP), the global
View HTML
Toggle Summary EDAP Announces New Board Member
U.S. Industry Veteran Rob Michiels Elected Director
View HTML